Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

NCT07154511 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease
Parkinson Disease Dementia

Interventions

DRUG: Tributyrin
DRUG: Placebo

Sponsor

Prabesh Kanel

Collaborators

[object Object]